bioRxivImmunologyPreprint
Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86
S. Turner, G. Amirthalingam, D. Bailey, D. H. Barouch, K. R. Bewley, K. Brown, Y. R. Cao, Y.-W. Chan, S. Charlton, DOVE consortium, N. S. Coombes, B. Hallis, D. D. Ho, F. Jian, N. Lasrado, R. Lassauniere, L. Lihong, D. C. Montefiori, P. Moss, J. Newman, H. Parry, C. Polacek Strandh, M. Rasmussen, F. Shao, X. Shen, , D. J. Smith
Abstract
The highly mutated SARS-CoV-2 variant, BA.2.86, and its descendants are now the most frequently sequenced variants of SARS-CoV-2. We analyze antibody neutralization data from eight laboratories from the UK, USA, Denmark, and China, including two datasets assessing the effect of XBB.1.5 vaccines, to determine the effect of infection and vaccination history on neutralization of variants up to and including BA.2.86, and produce antibody landscapes to describe these neutralization profiles. We find evidence for lower levels of immune imprinting on pre-Omicron variants in sera collected from Denmark and China, which may be explained by lower levels of circulation of the ancestral variant in these countries, and the use of an inactivated virus vaccine in China.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neutralisation of SARS-CoV-2 Omicron subvariants BA.2.86 and EG.5.1 by antibodies induced by earlier infection or vaccination
R. Lassauniere, C. Polacek, … M. Rasmussen·bioRxiv·Oct 1, 2023
- Vaccine imprinting drives increased SARS-CoV-2 variant infection in children
Timothy S. Johnston, Rahul Subramanian, … Daniel C. Douek·bioRxiv·Aug 17, 2026
- Repeated SARS-CoV-2 Antigenic Exposures from Prior Vaccinations and Infections Demonstrate Limits of Antibody Durability and Breadth Against Newer Variants
Wei Wang, Emilie Goguet, … Carol D. Weiss·bioRxiv·Apr 16, 2026
- SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variants
- Poor neutralizing antibody responses against SARS-CoV-2 Omicron BQ.1.1 and XBB in Norway in October 2022
E. L. Vikse, E. Fossum, … K. Bragstad·bioRxiv·Jan 5, 2023
- Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants
A. Banerjee, J. Lew, … D. Falzarano·bioRxiv·Jan 13, 2022